Skip to main content

Table 1 Baseline demographics of the patients involved in this research

From: Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer

Characteristics

Training cohort

(n = 100)

Validation cohort

(n = 48)

p value

Age, years

  

0.055

 Median [range]

58 [20, 76]

61 [42, 83]

 

Sex, no. (%)

  

0.220

 Male

79/100 (79%)

33/48 (68.75%)

 

 Female

21/100 (21%)

15/48 (31.25%)

Smoking, no. (%)

  

0.707

 Yes

70/100 (70%)

32/48 (66.7%)

 

 No

30/100 (30%)

16/48 (33.3%)

 

Side, no. (%)

  

0.389

 Upper left lobe

34/100 (34%)

12/48 (25%)

 

 Lower left lobe

14/100 (14%)

8/48 (16.7%)

 

 Upper right lobe

22/100 (22%)

12/48 (25%)

 

 Middle right lobe

4/100 (4%)

2/48 (4.2%)

 

 Lower right lobe

26/100 (26%)

14/48 (29.1%)

 

Location, no. (%)

  

0.216

 Peripheral

63/100 (63%)

25/48 (52.1%)

 

 Central

37/100 (37%)

23/48 (47.9%)

 

LD, mma

  

0.230

 Median [range]

54 [10, 115]

43.5 [15, 100]

 

LPD, mma

  

0.838

 Median [range]

36.5 [8, 77]

35 [11, 90]

 

CEA, (ng/ml)a

  

0.380

 Median [range]

4.7 [0.486, 1135]

7.11 [1.19, 646.4]

 

Histological subtype, no. (%)

  

0.164

 Squamous cell carcinoma

50/100 (50%)

18/48 (37.5%)

 

 Adenocarcinoma

50/100 (50%)

30/48 (62.5%)

 
  1. aLD, LPD and CEA indicate the longest diameter, the longest perpendicular diameter, and carcinoembryonic antigen, respectively